SCHEMBL5770751

SCHEMBL5770751

Cc1ccc(-c2cc3nc(C)nc(O)c3[nH]2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 18/20 0.58
CDK5 Q00535 2/20 0.46
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46
CDK5R1 Q15078 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
ABL1 P00519 1/20 0.44
RET P07949 1/20 0.44
KDR P35968 1/20 0.44
CDK7 P50613 1/20 0.44
PRKAA1 Q13131 1/20 0.44
AURKB Q96GD4 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773389 0.88 NPY5R (0.50) NPY5RCCNB2CDK1CCNB1CCNB3
SCHEMBL5774511 0.88 NPY5R (0.60) NPY5RCDK5CCNB2CDK1CCNB1
SCHEMBL5773995 0.88 NPY5R (0.68) NPY5R
SCHEMBL5773825 0.85 NPY5R (0.61) NPY5RCDK5CCNB2CDK1CCNB1
SCHEMBL5775579 0.82 NPY5R (0.45) NPY5R
SCHEMBL5773530 0.81 NPY5R (0.58) NPY5RCDK5CCNB2CDK1CCNB1
SCHEMBL5773718 0.81 NPY5R (0.46) NPY5R
SCHEMBL5774964 0.79 NPY5R (0.50) NPY5R
SCHEMBL5774435 0.76 NPY5R (0.48) NPY5R
SCHEMBL5775090 0.76 NPY5R (0.81) NPY5RCDK5CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed